Ambit Biosciences Corp (fka AMBI)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

03/09/23 5:14 AM

Post #51

9.07 -4.37 -32.51%

Hercules1

03/08/23 11:22 AM

Post #50

Recovery is under way.

This will go on to make new highs.

This is a good time to get in.

03/07/23 5:23 PM

Post #49

Re: #46: @Hercules1 - This will pop to $50 again. Just a matter

ouch 12.77 -4,48 ( -25,97 %)

Hercules1

03/07/23 2:39 PM

Post #48

Micro float.

77 percent institutional ownership.

$200 million in cash to fuel growth.

Rapid growth and expansion.

Zero float.

Combined enterprise value: $900 million.

Stock worth $75 on fundamentals alone.

Why would have this 77 percent institutional ownership:

Now you know the answer.

frans

03/07/23 12:27 PM

Post #47

GTSM short nice

Hercules1

03/07/23 11:59 AM

Post #46

This will pop to $50 again.

Just a matter of time.

This current price is a 600 percent discount.

Hercules1

03/07/23 11:08 AM

Post #45

Combined enterprise value is $900 million.

They are cash rich to fuel rapid growth.

77 percent institutional ownership.

Micro float.

Zero dilution.

This hit $50.50 a few days ago.

This can hit $75 at some point.

This dip is a golden opportunity to load some more.

$Pistol Pete$ Free

10/10/15 2:10 PM

Post #44

$AMBI Daily & Weekly Chart

Brad777c

12/08/14 3:42 PM

Post #43

So wheres my 4.50? lol

Brad777c

10/15/14 2:35 PM

Post #42

Well I called my broker and according to him its not a "forced" tender....optional....hmmmmm.....any ideas out there? Is there anybody out there? lol Its nice to have options though!

Brad777c

10/15/14 1:04 PM

Post #41

So whats the deal here? Should we call our broker and accept the tender offer or not accept? Does anyone know if a actual class action suit has been filed? Any suggestions? I was hoping to ride this baby to $60 a share but obviously the powers that be knew it was a winner and bought us out at 15. Now maybe its a good deal and maybe its not...just interested in others opinions.

I am a complete nobody...do not buy or sell due to my poor excuse for a comment!

crudeoil24 PremiumMember

09/29/14 10:03 AM

Post #40

Re: #39: @Brad777c - lol beginners luck. Had no idea we

Tender offer > On September 28, 2014, Ambit Biosciences Corporation (“Ambit”) and Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) issued a joint press release announcing the execution of an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the Merger Agreement, Charge Acquisition Corp., a wholly-owned subsidiary of Daiichi Sankyo (“Purchaser”), will commence a tender offer (the “Offer”) to purchase all of the issued and outstanding shares of Ambit common stock for (a) $15.00 per share in cash, plus (b) one non-transferrable contingent value right for each share of Ambit common stock, which represents the contractual right to receive up to $4.50 per share upon the achievement of certain commercialization-related milestones. If successful, the Offer will be followed by a merger of Purchaser with and into Ambit (the “Merger”).

Brad777c

09/29/14 9:46 AM

Post #39

Re: #38: @Stocktillyoudrop - Looks like you were right!

lol beginners luck. Had no idea we would move this fast. Nice!!

Stocktillyoudrop Free

09/29/14 9:20 AM

Post #38

Re: #37: @Brad777c - Time to load up now before the run

Looks like you were right!

Brad777c

09/17/14 2:54 PM

Post #37

Time to load up now before the run to 18-22 range imho! 8 is becoming a thing of the past...9 just the beginning of this!!!

All my opinion...risk to all stocks!

Brad777c

09/03/14 10:40 AM

Post #36

I told you at 6....then 7....now 8 dollars and climbing. We have a long way to go to 18 but we will be there before you know it. Don't say I didn't warn you!

All simply my humble opinion and anyone investing be prepared as always to lose everything.

Brad777c

09/02/14 10:58 AM

Post #35

I tried to tell you guys! Brace yourselves cause this baby is going to really take off now! Last chance to ride the big wave! Surfs up AMBI$$$$$$$$$$$$$$

Brad777c

08/29/14 8:50 AM

Post #34

loading....loading...loading.....$$$AMBI$$$....going to ride this wave a coming!

stocky101

07/18/14 5:57 PM

Post #33

Start loading up, I see the directors are

1984ISHERE Free

07/08/14 10:54 AM

Post #32

AMBI- Share Structure

Shares Outstanding5: 17.97M
Float: 5.07M

1984ISHERE Free

07/08/14 10:54 AM

Post #31

AMBI- Share Structure

Shares Outstanding5: 17.97M
Float: 5.07M

stocky101

01/17/14 3:46 PM

Post #30

She is gonna run to $11.50

stocky101

01/17/14 11:38 AM

Post #29

One seller is causing this to drop, don't be afraid to step in and buy, Mm's playing games to create more sellers.... Company assured me all is well and they are aware it's only one seller

stocky101

01/16/14 3:33 PM

Post #28

Re: #27: @BaylorTradeKing - Company has no rev yet. That's why. Any

Who know, we could close above $12 today!!!!!!

BaylorTradeKing Free

01/16/14 3:29 PM

Post #27

Re: #26: @stocky101 - This should easily be @ $18, not sure

Company has no rev yet. That's why.

Any snags in the pipeline really jack with valuation here. I have small position in at near bottom from first huge sell off. Damn FDA like to have things their way.

Good luck to ya. I hope you're right and we see the teens sooner than later.

stocky101

01/16/14 3:24 PM

Post #26

Re: #25: @BaylorTradeKing - Awesome. That's good news. Thanks for the update!

This should easily be @ $18, not sure what is holding it back bug it's coming soon, that amount doesn't even include the approval for any of the drugs

BaylorTradeKing Free

01/16/14 3:19 PM

Post #25

Re: #23: @stocky101 - IR called me back, sounds like one seller

Awesome. That's good news. Thanks for the update!

stocky101

01/16/14 3:19 PM

Post #24

Re: #20: @BaylorTradeKing - Keep me updated!

So, I'm going by his word and will continue to load up

stocky101

01/16/14 3:18 PM

Post #23

Re: #21: @BaylorTradeKing - Keep me updated!

IR called me back, sounds like one seller unloading a position....some of the buyers are actually on their way back from the JP Morgan Conference so there is a trade imbalance possibly allowing for these crazy swings, he told me the company is very upbeat on the future!!!

stocky101

01/16/14 3:09 PM

Post #22

Re: #18: @BaylorTradeKing - Any news / gossip on what might be

I'm not sure at all, called investor relations, gonna shoot over an email right now, this has me way down and very concerned

BaylorTradeKing Free

01/16/14 3:06 PM

Post #21

Re: #19: @stocky101 - I'm not sure at all, called investor relations,

Keep me updated!

BaylorTradeKing Free

01/16/14 3:05 PM

Post #20

Re: #19: @stocky101 - I'm not sure at all, called investor relations,

Keep me updated!

stocky101

01/16/14 3:04 PM

Post #19

Re: #18: @BaylorTradeKing - Any news / gossip on what might be

I'm not sure at all, called investor relations, gonna shoot over an email right now, this has me way down and very concerned

BaylorTradeKing Free

01/16/14 2:57 PM

Post #18

Re: #17: @stocky101 - Up and down today on high volume

Any news / gossip on what might be causing this?

stocky101

01/16/14 2:10 PM

Post #17

Up and down today on high volume

stocky101

12/31/13 2:56 PM

Post #16

Added more today

seattletrailrunr Free

12/24/13 2:58 AM

Post #15

Re: #14: @stocky101 - Getting ready to add 100,000 shares, perfect timing!!!!

Hope it worked out well for you, my friend! AMBI was a good find.

stocky101

12/18/13 10:11 AM

Post #14

Re: #13: @seattletrailrunr - Yes, Sir. I hope you caught the ride

Getting ready to add 100,000 shares, perfect timing!!!!

seattletrailrunr Free

12/15/13 9:24 PM

Post #13

Re: #12: @stocky101 - Hope your still in!!!!!

Yes, Sir. I hope you caught the ride as well! This isn't rocket science IMHO. Solid prospects with a good track record and past performance. Drives all of my selections on here. AMBI

stocky101

12/14/13 9:45 AM

Post #12

Re: #10: @seattletrailrunr - Caught the falling knife a little early yesterday,

Hope your still in!!!!!

surf1944

12/10/13 10:42 AM

Post #11

3:32AM Ambit Biosciences announces 4 presentations including results of phase 2b randomized, open-label study of lower doses of quizartinib in flt3 itd positive relapsed refractory acute myeloid leukemia patients (AMBI) 8.31 : Co announces four oral presentations given at the 55th Annual ASH Conference in New Orleans, with data highlighting the Company's lead drug candidate, quizartinib.

Results of the Phase 2b Randomized, Open-Label, Study of Lower Doses of Quizartinib in Subjects with FLT3-ITD Positive Relapsed Acute Myeloid Leukemia (AML): The purpose of this study is to assess the efficacy and safety of lower doses of quizartinib in the treatment of patients 18-years or older with relapsed/refractory FLT3 ITD positive AML to further improve the benefit:risk assessment of quizartinib.

This preliminary analysis is based on data available through May 28, 2013 with a minimum of eight weeks of follow up since the last subject first visit. A total of 76 patients were enrolled from May 21, 2012 to March 27, 2013. Median age for all patients was 55 (19-77) and 92% were FLT3-ITD. 35 patients remained in follow-up at the time of the analysis, and are currently censored for overall survival. The following key information was presented:

For dose of 30mg:

The CRc rate was 47 percent (5 percent CR+CRp, 42 percent CRi)
The rate of HSCT after quizartinib use was 32 percent
The median overall survival was 20.7 weeks, with 16/38 patients censored as they remained in follow-up at the time of the analysis
Of the 12 patients who were bridged to HSCT, the median overall survival was 31 weeks
Grade 2 or greater QT prolongation was 11%, with a 5% grade 3 rate and no grade 4 events
For dose of 60mg:

The CRc rate was 47 percent (5 percent CR+CRp, 42 percent CRi)
The rate of HSCT after quizartinib use was 42 percent
The median overall survival was 25.4 weeks, with 19/38 patients censored as they remained in follow-up at the time of the analysis
Of the 16 patients who were bridged to HSCT, the median overall survival is 28.1 weeks
Grade 2 or greater QT prolongation was 17%, with a 3% grade 3 rate and no grade 4 events
Overall conclusions: Both the 30mg and the 60mg doses showed substantial activity in terms of overall CRc rate and bridge to HSCT with impact on improved median OS. The safety profile is similar at both doses yet QTcF prolongation appears dose dependent, with decreased QTcF prolongation at both the 30 and 60mg doses compared to the prior Phase 2 study findings which utilized higher doses of quizartinib.

Next steps include a global phase 3 randomized study of quizartinib in FLT3-ITD(+) patients in 1st relapse planned to start in early 2014 pending final FDA feedback on our recommended starting dose.

seattletrailrunr Free

12/05/13 11:35 AM

Post #10

Re: #9: @stocky101 - Citi still bullish on Ambit despite no AA

Caught the falling knife a little early yesterday, but in for a solid position. Curious to see where we go from here. I like the number of candidates in the pipeline and the bullish sentiment across many analysts. All IMHO AMBI

stocky101

12/04/13 9:44 PM

Post #9

Citi still bullish on Ambit despite no AA for quizartinib
03:03 PM ET · AMBI

Citi maintains a Buy rating on Ambit Biosciences (AMBI -35.2%).
Although Citi reportedly says AA for quizartinib wasn't baked into the share price.
Price target lowered to $17 from $19.

stocky101

12/04/13 6:13 PM

Post #8

This should have only had a small pullback, volume was minimal, not sure of the share count but they are tight

stocky101

12/04/13 5:49 PM

Post #7

Re: #2: @TheFinalCD - down big on low vol* anyone know?

No big deal, it's going back I, way way way oversold!!!!!!

stocky101

12/04/13 12:22 PM

Post #6

Load time on this one. Will be huge in the near future

edgeice8

12/04/13 11:17 AM

Post #5

Re: #3: @edgeice8 - Wish I knew.

http://online.wsj.com/article/BT-CO-20131204-706121.html

edgeice8

12/04/13 11:17 AM

Post #4

Re: #3: @edgeice8 - Wish I knew.

http://online.wsj.com/article/BT-CO-20131204-706121.html

edgeice8

12/04/13 11:14 AM

Post #3

Re: #2: @TheFinalCD - down big on low vol* anyone know?

Wish I knew.

TheFinalCD PremiumMember

12/04/13 8:33 AM

Post #2

Re: #1: @ECole - AMBI presentation at 2013-Biotechnology-Industry-Organization-Investor-Forum

down big on low vol* anyone know?

Older

Ambit Biosciences Corp (fka AMBI)

Followers	1	Posters	15
Posts (Today)	0	Posts (Total)	51
Created	10/11/13	Type	Free
Moderators

Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

Board Info

Posts Today	0
Posts (Total)	51
Posters	15
Moderators

New Post

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Ambit Biosciences Corp (fka AMBI)

Ambit Biosciences Corp (fka AMBI)

Join the InvestorsHub Community

Ambit Biosciences Corp (fka AMBI)

Board Info